首页> Oncology: International Journal of Cancer Research and Treatment> A Possible Distinct Molecular Subtype (Quintuple-Wildtype) of Metastatic Colorectal Cancer in First-Line Anti-EGFR Therapy with Cetuximab Plus FOLFIRI – Palliative Precision Therapy and a Multidisciplinary Treatment Approach: Interim Analysis of the IVOPAK II Trial with Early Results

A Possible Distinct Molecular Subtype (Quintuple-Wildtype) of Metastatic Colorectal Cancer in First-Line Anti-EGFR Therapy with Cetuximab Plus FOLFIRI – Palliative Precision Therapy and a Multidisciplinary Treatment Approach: Interim Analysis of the IVOPAK II Trial with Early Results

导出原文传递

翻译打印收藏纠错

第一作者： Axel,Wein

作者： Axel,Wein ^[1] ; Robert,Stoehr ^[2] ; Stephan,Kersting ^[3] ; Jürgen,Siebler ^[4] ; Susanne,Merkel ^[5] ; Dagmar,Busse ; Kerstin,Wolff ; Nicola,Ostermeier ; Clemens,Neufert ; Francesco,Vitali ; Markus,Eckstein ; Jan-Peter,Roth ; Peter,Anhut ; Waldemar,Schreiner ; Michael,Uder ; Arndt,Hartmann ; Markus F.,Neurath ; Robert,Grützmann

作者单位： Department of Radiology, Friedrich–Alexander University Erlangen–Nuremberg, Erlangen, Germany ^[1] Department of Pathology, Friedrich–Alexander University Erlangen–Nuremberg, Erlangen, Germany ^[2] Department of Surgery, Friedrich–Alexander University Erlangen–Nuremberg, Erlangen, Germany ^[3] Medical Practice of Oncology, Kronach, Germany ^[4] Department of Internal Medicine 1, Gastroenterology, Pulmonology, and Endocrinology, Friedrich ^[5]

关键词 Colorectal neoplasms Palliative first-line therapy Interdisciplinary collaboration Continuous check strategy Secondary metastatic resection rate

发布时间 2022-03-21

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交